AI assistant
10x Genomics, Inc. — Director's Dealing 2020
Nov 5, 2020
31830_dirs_2020-11-04_69f663a5-3966-4649-bca9-855ee5b30f22.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-11-02
Reporting Person: STUELPNAGEL JOHN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-02 | Class A Common Stock | S | 2328 | $135.6197 | Disposed | 516163 | Direct |
| 2020-11-02 | Class A Common Stock | S | 3900 | $136.2297 | Disposed | 512263 | Direct |
| 2020-11-02 | Class A Common Stock | S | 772 | $137.473 | Disposed | 511491 | Direct |
| 2020-11-02 | Class A Common Stock | S | 500 | $139.034 | Disposed | 510991 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $134.93 to $135.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: This transaction was executed in multiple trades at prices ranging from $135.93 to $136.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $136.96 to $137.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $138.33 to $139.23. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.